Kades & Cheifetz LLC Amgen Inc Transaction History
Kades & Cheifetz LLC
- $195 Billion
- Q4 2024
A detailed history of Kades & Cheifetz LLC transactions in Amgen Inc stock. As of the latest transaction made, Kades & Cheifetz LLC holds 835 shares of AMGN stock, worth $226,836. This represents 0.11% of its overall portfolio holdings.
Number of Shares
835
Previous 1,052
20.63%
Holding current value
$226,836
Previous $339 Million
35.76%
% of portfolio
0.11%
Previous 0.19%
Shares
6 transactions
Others Institutions Holding AMGN
# of Institutions
3,306Shares Held
429MCall Options Held
8.06MPut Options Held
7.7M-
Vanguard Group Inc Valley Forge, PA52.9MShares$14.4 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.5 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$7.93 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.54 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.41 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $145B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...